KR890701591A - 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체 - Google Patents

4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체

Info

Publication number
KR890701591A
KR890701591A KR1019890700918A KR890700918A KR890701591A KR 890701591 A KR890701591 A KR 890701591A KR 1019890700918 A KR1019890700918 A KR 1019890700918A KR 890700918 A KR890700918 A KR 890700918A KR 890701591 A KR890701591 A KR 890701591A
Authority
KR
South Korea
Prior art keywords
compound
formula
alkylmethylcarbonyl
salt
trilower
Prior art date
Application number
KR1019890700918A
Other languages
English (en)
Inventor
트락슬러 페터
뮐러 클라우스
쿰프 빌헤름
Original Assignee
베르너 발데그
시바-가이기 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베르너 발데그, 시바-가이기 에이지 filed Critical 베르너 발데그
Publication of KR890701591A publication Critical patent/KR890701591A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (14)

  1. 일반식(Ⅰ)의 화합물 및 이의염.
    상기식에서, R저급알킬이고, R1은 트리저급알킬메틸카보닐이며, R2및 R3라디칼 중 하나는 트리저급알킬메틸카보닐이고 다른 하나는 수소이다.
  2. 제1항에 있어서, R이 저급알킬, 특히 메틸이고, R1및 R2가 트리저급알킬메틸카보닐(여기서, 저급알킬은 탄소수 2이하이다)이고 ㄱ3가 수소이거나, R1및 R3가 트리저급알킬메틸카보닐(여기서, 저급알킬은 탄소수 2이하이다) 이고 R2가 수소인 일반식(Ⅰ)의 화합물 및 이의염.
  3. 제1항에 있어서, R이 메틸이고, R1및 R2는 피발로일이고, R3가 수소이거나, R1및 R3가 피발로일이고 R2가 수소인 일반식(Ⅰ)의 화합물및 이의염.
  4. 제1항에 있어서, 8-1,21-0-디-피발로일-3-[4-(2,4,6-트리메틸벤질)-1-피페라지닐]-리파마이신 S인 일반식(Ⅰ)의 화합물및 이의 염.
  5. 제1항에 있어서, 8-O,N-디-피발로일-3-[4-(2,4,6-트리메틸벤질)-1-피페라지닐]-리파마이신 S인 일반식(Ⅰ)의 화합물 및 이의 염.
  6. 제1 내지 5항중 어느 한 항에 따른 일반식(Ⅰ)의 화합물의 약제학적으로 허용되는 염.
  7. 약제로서, 특히 저지질혈증제로의 제1 내지 6항중 어느 한항에 따른 화합물.
  8. 제1 내지 6항중 어느 한 항에 따른 화합물을 함유하는 약제학적 제재.
  9. 약제로서, 특히 저지질혈증제로서의 제1 내지 6항중 어느 한항에 따른 용도.
  10. 일반식(Ⅱ)의 화합물을 트리저급알킬메틸카보닐 라디칼 R1및 R2또는 R1및 R3를 8위치 및 환성 아미드질소원자 또는 8위치 및 21위치에 도입시키는 아실화제로 처리하고, 필요한 경우, 방법에 따라 제조된 혼합물을 이성체들로부터 분리시키고/시키거나, 방법에 따라 제조된 염을 유리화합물로 또는 다른 염으로 전환시키고/ 시키거나, 방법에 따라 제조된 유리화합물을 염으로 전환시킴으로 특징으로 하여, 제1항에 따른 일반식(Ⅰ)의 화합물을 제조하는 방법.
    상기식에서, R은 상기 정의한 바와같다.
  11. 제10항에 있어서, 트리저급알킬메틸카보닐 라디칼에 상응하는 탄산 또는 이의 반응성 유도체를 사용함을 특징으로 하는 방법.
  12. 제11항에 있어서, 탄산의 상응하는 무수물, 특히 혼합된 무수물을 사용하는 방법.
  13. 제12항에 있어서, 상응하는 산할로겐나이트, 특히 산클로라이드를 사용하는 방법.
  14. 제1항에 따른 일반식(Ⅰ)의 화합물(여기서, R,R1,R,R2는 제1항에 기술된 의미와 같다) 또는 이의 염을 필요한 경우, 담체물질과 함께 약리학적 재제로 제형화 시킴을 특징으로 하여, 약제학적 제재를 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890700918A 1987-09-25 1987-09-25 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체 KR890701591A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH1987/000123 WO1989002894A1 (en) 1987-09-25 1987-09-25 Diacyl derivatives of 4-(trialkylbenzyl)-piperazinyl compounds

Publications (1)

Publication Number Publication Date
KR890701591A true KR890701591A (ko) 1989-12-21

Family

ID=4543936

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890700918A KR890701591A (ko) 1987-09-25 1987-09-25 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체

Country Status (8)

Country Link
US (1) US4916126A (ko)
JP (1) JPH02501301A (ko)
KR (1) KR890701591A (ko)
AU (1) AU621811B2 (ko)
DK (1) DK81089A (ko)
FI (1) FI87567C (ko)
NO (1) NO167204C (ko)
WO (1) WO1989002894A1 (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890701592A (ko) * 1987-10-27 1989-12-21 베르너 발데그 치환된 아자사이클로 헥실-유도체
GB8725118D0 (en) * 1987-10-27 1987-12-02 Ciba Geigy Ag Rifamycin derivatives
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides
US5180718A (en) * 1989-03-02 1993-01-19 Ciba-Geigy Corporation Acyl derivatives of oxazolorifamycins
CA2214072C (en) * 1996-08-29 2006-11-14 Eli Lilly And Company Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
CA2214070C (en) * 1996-08-29 2006-03-14 Eli Lilly And Company Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
MY118009A (en) * 1996-09-25 2004-08-30 Lilly Co Eli Process for the synthesis of benzothiophenes
CA2214931A1 (en) * 1996-09-26 1998-03-26 Henry Uhlman Bryant Tetrahydrobenzo-a-fluorene compounds and method of use
CA2214922A1 (en) * 1996-09-27 1998-03-27 Eli Lilly And Company Benzothiophene compounds, compositions, and methods
CA2214872C (en) * 1996-10-24 2002-01-22 Eli Lilly And Company Benzothiophene compounds, compositions and methods
CA2216592C (en) * 1996-10-24 2006-07-18 Brian Stephen Muehl Benzothiophene compounds, intermediates, compositions, and methods
CA2215647A1 (en) * 1996-10-24 1998-04-24 Eli Lilly And Company Naphthyl compounds, compositions, and methods
AU7467398A (en) * 1997-04-25 1998-11-24 Eli Lilly And Company Indene compounds having activity as serms
CA2287920A1 (en) * 1997-04-30 1998-11-05 Eli Lilly And Company Intermediates and a process for preparing benzo¬b|thiophenes
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
WO2004054548A1 (en) * 2002-12-12 2004-07-01 Activbiotics,Inc. Method and reagents for treating or preventing atherosclerosis and diseases associated therewith

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (ko) * 1964-07-31
US4261891A (en) * 1965-08-24 1981-04-14 Ciba-Geigy Corporation Antibiotically active rifamycin derivatives
US4005077A (en) * 1965-08-24 1977-01-25 Ciba-Geigy Corporation Antibiotically active compounds
CH484898A (de) * 1967-05-29 1970-01-31 Ciba Geigy Verfahren zur Herstellung von 3-Formylrifamycin SV
CH507977A (de) * 1967-06-16 1971-05-31 Ciba Geigy Ag Verfahren zur Herstellung von 3-Formylrifamycin-SV
IT1046627B (it) * 1970-06-01 1980-07-31 Lepetit Spa Composizioni antivirali contenenti derivati della rifaumicina sv
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GB1486118A (en) * 1975-03-05 1977-09-21 Lepetit Spa Rifamycin derivatives
GR64108B (en) * 1977-04-15 1980-01-24 Dso Pharmachim Method for the preparation of azomethine-derivatives of rifamycin s.v
GB8308166D0 (en) * 1983-03-24 1983-05-05 Erba Farmitalia Preparation of azinomethyl-rifamycins
GB8318072D0 (en) * 1983-07-04 1983-08-03 Lepetit Spa Water-soluble rifampicin derivatives
US4681938A (en) * 1984-08-27 1987-07-21 Ciba-Geigy Corporation Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis
US4551450A (en) * 1984-08-27 1985-11-05 Ciba-Geigy Corporation Rifamycin hydrazones, pharmaceutical compositions containing them and their use
US4631290A (en) * 1985-08-29 1986-12-23 American Home Products Corporation Method of treating hepatitis
AU582799B2 (en) * 1985-10-18 1989-04-13 Ciba-Geigy Ag Substituted 4-benzyl-piperazinyl compounds
JPS63501712A (ja) * 1985-10-18 1988-07-14 チバ−ガイギ− アクチエンゲゼルシヤフト 置換４−ベンジルピペラジニル化合物
US4774237A (en) * 1986-02-14 1988-09-27 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Expellants of phytopathogenic microbes

Also Published As

Publication number Publication date
FI87567B (fi) 1992-10-15
DK81089A (da) 1989-04-06
WO1989002894A1 (en) 1989-04-06
JPH02501301A (ja) 1990-05-10
NO885806D0 (no) 1988-12-29
FI885424A (fi) 1989-03-26
FI885424A0 (fi) 1988-11-23
AU621811B2 (en) 1992-03-26
US4916126A (en) 1990-04-10
NO885806L (no) 1989-03-06
DK81089D0 (da) 1989-02-22
AU7917687A (en) 1989-04-18
NO167204C (no) 1991-10-23
NO167204B (no) 1991-07-08
FI87567C (fi) 1993-01-25

Similar Documents

Publication Publication Date Title
KR890701591A (ko) 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체
DE2966269D1 (en) 1-, 6- and 2-substituted-1-carba-2-penem-3-carboxylic acids, process for preparing the same and pharmaceutical compositions containing the same
HUT37128A (en) Process for the production of dihydropyridazinone-derivatives, as well as of pharmaceutical preparations containing these derivatives as agent
KR880013888A (ko) 신규 디티오아세탈 화합물, 그의 제조방법 및 이 화합물로 되는 제약 조성물
DE3850475D1 (de) Wässrige Polyurethan Dispersionen.
AU3559193A (en) New 3',5'-di-tert-butyl-4'-hydroxy flavones, process for the preparation thereof and pharmaceutical compositions containing them
EP0193148A3 (en) 8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-(alkoxy-containing acyl)hydrazides
ES8500948A1 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
IL57691A0 (en) New 3,20-dioxo-4,9-diene-21-hydroxyl steroid derivatives,process for preparing them and their use as medicaments and the pharmaceutical compositions containing them
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
KR850000978A (ko) 데포우 소염제의 제조방법
KR840006475A (ko) 나프탈렌 유도체의 제조방법
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR880009926A (ko) 알킬멜라토닌
GB2243605A (en) Fluorinated 4"-cyano substituted terphenyls
EP0233745A3 (en) Chemical compounds
KR850000415A (ko) 퀴나졸리논 유도체의 제조방법
ATE54446T1 (de) Substituierte azabicycloheptane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
ES487631A1 (es) Procedimiento para la obtencion de hexahidro-1,4-oxazepinas
KR900006309A (ko) 신규 2-카르보닐 치환 n, n'-디-(트리메톡시벤조일)피페라진, 이들의 제조방법 및 이들을 함유한 치료 조성물
KR850003382A (ko) 디아릴인단-1,3-디온의 제조방법
KR880012544A (ko) 벤젠설폰아미드 유도체 및 그의 제조방법
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR870001172A (ko) 신규한 벤즈아미드의 제법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid